Bioactive Compounds List
Type Distribution
Max Phase Distribution
Bioactive Compounds List
| Bio ID | Target ID | Target Name | ChEMBL ID | Name | Type | Max Phase | Molecular Weight | Targets | Bioactivities | Molecular Formula | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|
| bio3511 | Tar18 | Serine/threonine-protein kinase cot (COT) | CHEMBL1269155 | EFETOZOLE | Small molecule | Phase 2 | 186.26 | 4.0 | 6.0 | C12H14N2 | Details |
| bio3512 | Tar18 | Serine/threonine-protein kinase cot (COT) | CHEMBL2105685 | AMUVATINIB HYDROCHLORIDE | Small molecule | Unknown | 483.98 | 14.0 | 179.0 | C23H22ClN5O3S | Details |
| bio3513 | Tar18 | Serine/threonine-protein kinase cot (COT) | CHEMBL2289111 | N PHTHALOYL-L-THREONINE | Small molecule | -- | 249.22 | 4.0 | 13.0 | C12H11NO5 | Details |
| bio3514 | Tar18 | Serine/threonine-protein kinase cot (COT) | CHEMBL2103871 | ALISERTIB SODIUM | Small molecule | Unknown | 558.93 | -- | -- | C27H21ClFN4NaO5 | Details |
| bio3515 | Tar18 | Serine/threonine-protein kinase cot (COT) | CHEMBL4298071 | HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN | Unknown | Phase 3 | -- | -- | -- | -- | Details |
| bio3516 | Tar18 | Serine/threonine-protein kinase cot (COT) | CHEMBL4447181 | LONDAMOCITINIB | Small molecule | Phase 2 | 599.66 | 8.0 | 53.0 | C28H31F2N7O4S | Details |
| bio3517 | Tar18 | Serine/threonine-protein kinase cot (COT) | CHEMBL2159227 | CEMDOMESPIB | Small molecule | Phase 2 | 447.50 | 7.0 | 20.0 | C24H30FNO6 | Details |
| bio3518 | Tar18 | Serine/threonine-protein kinase cot (COT) | CHEMBL1908306 | EFLUCIMIBE | Small molecule | Phase 2 | 469.74 | 3.0 | 7.0 | C29H43NO2S | Details |
| bio3519 | Tar18 | Serine/threonine-protein kinase cot (COT) | CHEMBL324954 | EFEGATRAN SULFATE | Protein | Unknown | 514.61 | 1.0 | 1.0 | C21H34N6O7S | Details |
| bio3520 | Tar18 | Serine/threonine-protein kinase cot (COT) | CHEMBL2106443 | EFROTOMYCIN | Oligosaccharide | Phase 2 | 1145.35 | -- | -- | C59H88N2O20 | Details |